BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,605,031 | +4.6% | 791,671 | +4.0% | 1.70% | +2.5% |
| Q2 2023 | $5,356,764 | +11.2% | 760,904 | +31.7% | 1.66% | -16.7% |
| Q1 2023 | $4,818,493 | +54.2% | 577,757 | +112.3% | 1.99% | +122.5% |
| Q4 2022 | $3,124,546 | +32.9% | 272,173 | +45.9% | 0.89% | +12.5% |
| Q3 2022 | $2,351,000 | +315.4% | 186,603 | +248.7% | 0.80% | +356.9% |
| Q2 2022 | $566,000 | +187.3% | 53,521 | -47.7% | 0.17% | +112.2% |
| Q1 2022 | $197,000 | -76.0% | 102,425 | -6.9% | 0.08% | -82.8% |
| Q4 2020 | $820,000 | – | 110,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |